Navigation Links
2 Independent Studies Released on the Effectiveness of Prostate Cancer Treatment
Date:9/1/2009

WESTMONT, Ill., Sept. 1 /PRNewswire/ -- For years, the debate has been ongoing regarding the best treatment method for prostate cancer patients. Now, two independent studies have reached similar conclusions. Already considered a good option for prostate cancer patients, brachytherapy (radiation seed implants) now has the backing of research from the Prostate Cancer Foundation of Chicago and The Taussig Cancer Center at Cleveland Clinic, proving a superior disease-free survival rate for patients with early stage prostate cancer.

In an 11-year study, the Prostate Cancer Foundation of Chicago, a non-profit organization that funds patient support programs, clinical research and public education, analyzed 9,137 patients between 1997 and 2008 who were treated for prostate cancer with brachytherapy at Chicago Prostate Center. 67.5% of the patients were regarded as low risk, 29.36% as intermediate, and 1.01% as high.

Of those patients, overall cure rates were 96%, 84%, and 75% for low, intermediate, and high risk patients, respectively. When combined with external beam radiation therapy in intermediate and high risk patients, the brachytherapy results far exceed those of surgery.

The Taussig Cancer Center at Cleveland Clinic has released their similar 2008 outcomes, demonstrating brachytherapy to be superior to surgery in all cases. For low risk patients, the study found a 95% survival rate after five years, 89% for intermediate risk, and 71% for high risk patients. This research concluded that, for low risk patients, brachytherapy was equally successful as external beam radiation, but more successful than a radical prostatectomy.

In addition to its effectiveness, brachytherapy is a minimally invasive treatment. Patients with prostate cancer in the T1 or T2 stages (meaning the cancer hasn't spread beyond the prostate) choose brachytherapy for a number of reasons:

  • No incisions, minimal pain and blood loss
  • Urinary incontinence rates less than 1% - compared to 10% with surgery
  • 6-25% chance of sexual dysfunction following procedure - compared to 50% with surgery
  • Lower rates of bowel irritation compared to external beam radiation
  • Convenience - one-time, outpatient procedure, patients can return to normal activity within a day
  • Lower cost compared to external beam radiation and surgery

For more information on the Prostate Cancer Foundation of Chicago research, visit www.chicagoprostatefoundation.org. For more information on the Taussig Cancer Center at Cleveland Clinic, visit http://my.clevelandclinic.org/services/radiation_oncology/outcomes.aspx.


'/>"/>
SOURCE Prostate Cancer Foundation of Chicago
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
2. PCMA Statement on the Independent Drugstore Lobby Agenda
3. Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Managements Internal Control Review Efforts and on Legal Proceedings
4. IRIDEX Appoints Burr, Pilger & Mayer New Independent Auditor
5. Nationwide independent Taser study results suggest devices are safe
6. KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants
7. Schwab Institutional Introduces Healthcare and Benefits Assistance for Independent Advisor Firms
8. GHI to Provide Independent Personal Health Advocate for Medicare Members
9. PCMA Statement on Independent Pharmacy Antitrust Legislation
10. Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc.
11. Medical Services Receives Independent Test Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... ... Living (IHCA/INCAL), will serve as a healthcare industry expert at the 2017 Sector ... discussion, moderated by Inside Indiana Business host Gerry Dick, will feature an employer ...
(Date:1/23/2017)... Greifensee, Switzerland (PRWEB) , ... January 23, 2017 ... ... many lab and production applications. However, choosing the right method is paramount to ... may occur more often in situations where multiple persons use the same equipment. ...
(Date:1/23/2017)... ... 23, 2017 , ... "ProRandom is a set of camera tools that allow video editors to ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , With ... with video footage. ProRandom works by using a virtual camera to create the illusion ...
(Date:1/23/2017)... (PRWEB) , ... January 23, ... ... Education Foundation (OREF), in partnership with the American Society of Anesthesiologists® (ASA®), ... Foundation (APSF), the American Academy of Orthopaedic Surgeons (AAOS) and the Cigna ...
(Date:1/23/2017)... , ... January 23, 2017 , ... “The Inn at the Mill”: a story ... fears in her quest to become happy and content. , “The Inn at the ... has also lived in Germany and Vermont and is now living in Berks County on ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... January 23, 2017 Ahead of today,s trading ... how they have fared at the close: Kite Pharma Inc. (NASDAQ: ... OVAS ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... were relative laggards on Friday, January 20 th , 2017, down ... research reports on these stocks now at: ...
(Date:1/23/2017)... , January 23, 2017 A new ... Testing Market was valued at US$0.53 bn in 2013 and ... a strong 17.50% CAGR between 2014 and 2022. The title of ... Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022." ... Non-invasive prenatal testing ...
(Date:1/23/2017)... The global  anxiety disorders and depression treatment market  is expected to reach ... worldwide is anticipated to drive the market growth in the coming years. Increasing ... in the recent years. Continue Reading ... ... ...
Breaking Medicine Technology: